SVWAG
Sound View Wealth Advisors Group’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.28M | Buy |
2,443
+214
| +10% | +$112K | 0.09% | 167 |
|
|
2025
Q1 | $1.41M | Buy |
2,229
+2
| +0.1% | +$1.27K | 0.12% | 145 |
|
|
2024
Q4 | $1.59M | Buy |
2,227
+183
| +9% | +$130K | 0.13% | 136 |
|
|
2024
Q3 | $2.15M | Buy |
2,044
+83
| +4% | +$87.3K | 0.18% | 120 |
|
|
2024
Q2 | $2.06M | Sell |
1,961
-193
| -9% | -$203K | 0.21% | 108 |
|
|
2024
Q1 | $2.07M | Sell |
2,154
-38
| -2% | -$36.6K | 0.22% | 107 |
|
|
2023
Q4 | $1.93M | Buy |
2,192
+10
| +0.5% | +$8.78K | 0.21% | 114 |
|
|
2023
Q3 | $1.8M | Buy |
2,182
+75
| +4% | +$61.7K | 0.22% | 99 |
|
|
2023
Q2 | $1.51M | Buy |
2,107
+34
| +2% | +$24.4K | 0.2% | 110 |
|
|
2023
Q1 | $1.7M | Sell |
2,073
-119
| -5% | -$97.8K | 0.23% | 95 |
|
|
2022
Q4 | $1.93M | Buy |
2,192
+210
| +11% | +$184K | 0.21% | 114 |
|
|
2022
Q3 | $1.37M | Buy |
1,982
+62
| +3% | +$42.7K | 0.31% | 82 |
|
|
2022
Q2 | $1.14M | Sell |
1,920
-1
| -0.1% | -$591 | 0.24% | 104 |
|
|
2022
Q1 | $1.34M | Sell |
1,921
-32
| -2% | -$22.4K | 0.26% | 97 |
|
|
2021
Q4 | $1.23M | Sell |
1,953
-2
| -0.1% | -$1.26K | 0.23% | 105 |
|
|
2021
Q3 | $1.18M | Buy |
1,955
+2
| +0.1% | +$1.21K | 0.25% | 102 |
|
|
2021
Q2 | $1.09M | Buy |
1,953
+20
| +1% | +$11.2K | 0.23% | 107 |
|
|
2021
Q1 | $915K | Sell |
1,933
-23
| -1% | -$10.9K | 0.21% | 108 |
|
|
2020
Q4 | $945K | Buy |
1,956
+4
| +0.2% | +$1.93K | 0.23% | 104 |
|
|
2020
Q3 | $1.09M | Sell |
1,952
-25
| -1% | -$14K | 0.29% | 91 |
|
|
2020
Q2 | $1.23M | Sell |
1,977
-132
| -6% | -$82.3K | 0.35% | 84 |
|
|
2020
Q1 | $1.03M | Sell |
2,109
-61
| -3% | -$29.8K | 0.36% | 80 |
|
|
2019
Q4 | $815K | Sell |
2,170
-24
| -1% | -$9.01K | 0.23% | 105 |
|
|
2019
Q3 | $609K | Sell |
2,194
-33
| -1% | -$9.16K | 0.18% | 124 |
|
|
2019
Q2 | $697K | Buy |
+2,227
| New | +$697K | 0.21% | 119 |
|